The Immunophenotype of Bone Marrow Lymphocytes in Children with Immune Thrombocytopenic Purpura

REFERENCES

• Papagiannia A, Economou M, Tragiannidisb A, FcgRIIa and FcgRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome. Blood Coag Fibrinol. 2013;24:35–39.
   PubMedGoogle Scholar
• Xu J, Lu S, Tao J, CD72 polymorphism associated with child-onset of idiopathic thrombocytopenic purpura in Chinese patients. J Clin Immunol. 2008;28:214–219.
   PubMed Web of Science ®Google Scholar
• Douglas B. Cines MD, Victor S, Immune Thrombocytopenic Purpura. N Eng J Med. 2002;346:995–1008.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–2393.
   PubMed Web of Science ®Google Scholar
• Chen JF YL, Feng JJ, Chang LX, The clinical significance of immune-related marker detection in idiopathic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi. 2010;49:765–768.
   PubMedGoogle Scholar
• Parodi E, Nobili B, Perrotta S, Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment. Int J Hematol. 2006;84:364–374.
   Google Scholar
• Arnold DM, Dentali F, Crowther MA, Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25–33.
   PubMed Web of Science ®Google Scholar
• Callea V, Comis M, Iaria G, Clinical significance of HLA-DR+, CD19+, CD10+ immature B-cell phenotype and CD34+ cell detection in bone marrow lymphocytes from children affected with immune thrombocytopenic purpura. Haematologica. 1997;82:471–473.
   PubMedGoogle Scholar
• Sandhaus LM, Chen TL, Ettinger LJ, Significance of increased proportion of CD10-positive cells in nonmalignant bone marrows of children. Am J Pediatr Hematol Oncol. 1993;15:65–70.
   PubMedGoogle Scholar
• Cornclius AS, Campbell D, Schwartz E, Elevated common acute lymphoblasitic leukemia antigen expression in pediatric immune thrombocytopenic purpura. J Pediatr Hematol/Oncol. 1991;13:57–61.
   Google Scholar
• Nitschke L, Wöhner M. A genetically modified rodent expressing human CD22. EP Patent. 2013;2:554,048.
   Google Scholar
• Vaughan W, Civin C, Weisenburger D, Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia. 1988;2:661–666.
   PubMed Web of Science ®Google Scholar
• Guiziry D, El G, Farahat N, Hassab H. Phenotypic analysis of bone marrow lymphocytes from children with acute thrombocytopenic purpura. Egypt J Immunol. 2004;12:9–14.
   Google Scholar
• Li X ZH, Bao W, Boulad N, Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood. 2012;18:3318–3325.
   Google Scholar
• Caldwell CW, Poje E, Helikson MA. B-cell precursors in normal pediatric bone marrow. Am J Clin Pathol. 1991;95:816–823.
   PubMed Web of Science ®Google Scholar
• LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112:1570–1580.
   PubMed Web of Science ®Google Scholar
• Boshkov LK, Kelton JG, Halloran PF. HLA‐DR expression by platelets in acute idiopathic thrombocytopenic purpura. Br J Haematol. 1992;81:552–557.
   PubMed Web of Science ®Google Scholar
• Chang DY OJ, Zhou RF, Xu JY, Profiles of different subsets of CD(4)(+) T cells in chronic idiopathic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi. 2010;49:213–216.
   PubMedGoogle Scholar
• Sameshima S, Nakao M, Somamoto T. Diversity of CD2 subfamily receptors in cyprinid fishes. Results in Immunology. 2012;2:25–34.
   PubMedGoogle Scholar
• Smith CA, Williams GT, Kingston R, Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 1989;337(6203):181–184.
   PubMed Web of Science ®Google Scholar
• Semple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev. 2002;16:9–12.
   PubMed Web of Science ®Google Scholar
• Bayry JTM, Delignat S, Misra N, Dendritic cells and autoimmunity. Autoimmune Rev. 2004;3:183–187.
   PubMed Web of Science ®Google Scholar
• Hu Y MD, Shan NN, Zhu YY, Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia. PLoS One. 2011;6:e26522.
   PubMed Web of Science ®Google Scholar
• Carcao MD, Blanchette VS, Wakefield CD, Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. Br J haematol. 2003;120:135–141.
   PubMed Web of Science ®Google Scholar
• Curnow RT. Clinical experience with CD64-directed immunotherapy. An overview. Cancer Immunology, Immunotherapy. 1997;45:210–215.
   PubMed Web of Science ®Google Scholar